Suppr超能文献

200株对青霉素敏感和耐药的肺炎球菌对哌拉西林、哌拉西林-他唑巴坦、替卡西林、替卡西林-克拉维酸、氨苄西林、氨苄西林-舒巴坦、头孢他啶和头孢曲松的敏感性。

Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.

作者信息

Pankuch G A, Jacobs M R, Appelbaum P C

机构信息

Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033.

出版信息

Antimicrob Agents Chemother. 1994 Dec;38(12):2905-7. doi: 10.1128/AAC.38.12.2905.

Abstract

MICs of eight beta-lactams (piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone) were determined by agar dilution against 64 penicillin-susceptible, 70 intermediately penicillin-resistant, and 66 fully penicillin-resistant pneumococci. The MICs of piperacillin with and without tazobactam for 90% of the susceptible, intermediately resistant, and resistant strains tested (MIC90s) were < or = 0.064, 2.0, and 4.0 micrograms/ml, respectively. By comparison, those of ampicillin with and without sulbactam were 0.125, 2.0, and 4.0 micrograms/ml and those of ceftriaxone were < or = 0.064, 1.0, and 2.0 micrograms/ml, respectively. Strains were less susceptible to ticarcillin with and without clavulanate (MIC90s, 2.0, 64.0, and 128.0 micrograms/ml) and ceftazidime (MIC90s, 1.0, 8.0, and 32.0 micrograms/ml).

摘要

采用琼脂稀释法测定了8种β-内酰胺类抗生素(哌拉西林、哌拉西林-他唑巴坦、替卡西林、替卡西林-克拉维酸、氨苄西林、氨苄西林-舒巴坦、头孢他啶和头孢曲松)对64株青霉素敏感、70株中度青霉素耐药和66株完全青霉素耐药肺炎球菌的最低抑菌浓度(MIC)。哌拉西林单用及与他唑巴坦联用对90%受试敏感、中度耐药和耐药菌株的MIC90分别≤0.064、2.0和4.0微克/毫升。相比之下,氨苄西林单用及与舒巴坦联用的MIC90分别为0.125、2.0和4.0微克/毫升,头孢曲松的MIC90分别≤0.064、1.0和2.0微克/毫升。菌株对替卡西林单用及与克拉维酸联用(MIC90分别为2.0、64.0和128.0微克/毫升)以及头孢他啶(MIC90分别为1.0、8.0和32.0微克/毫升)的敏感性较低。

相似文献

4
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
Antimicrob Agents Chemother. 1995 Jul;39(7):1499-504. doi: 10.1128/AAC.39.7.1499.
7
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Antimicrob Agents Chemother. 1989 Aug;33(8):1268-74. doi: 10.1128/AAC.33.8.1268.
10
Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
Antimicrob Agents Chemother. 1993 May;37(5):1174-6. doi: 10.1128/AAC.37.5.1174.

引用本文的文献

1
Canadian Antibiotic Prescribing for Sepsis (CAPS) Study: A Analysis of the FABLED Cohort Study.
J Assoc Med Microbiol Infect Dis Can. 2024 Dec 19;9(4):239-248. doi: 10.3138/jammi-2024-0024. eCollection 2024 Dec.
2
Streptococcus pneumoniae: Activity of Newer Agents Against Penicillin-Resistant Strains.
Curr Infect Dis Rep. 1999 Apr;1(1):13-21. doi: 10.1007/s11908-999-0004-8.
3
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Drugs. 1999 May;57(5):805-43. doi: 10.2165/00003495-199957050-00017.
4
Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1997 Feb;41(2):478-80. doi: 10.1128/AAC.41.2.478.
5
Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland.
J Clin Microbiol. 1995 Dec;33(12):3159-63. doi: 10.1128/jcm.33.12.3159-3163.1995.
7
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
Antimicrob Agents Chemother. 1995 Jul;39(7):1499-504. doi: 10.1128/AAC.39.7.1499.

本文引用的文献

1
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
J Antimicrob Chemother. 1993 Jan;31 Suppl A:39-60. doi: 10.1093/jac/31.suppl_a.39.
2
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
N Engl J Med. 1994 Aug 11;331(6):377-82. doi: 10.1056/NEJM199408113310607.
7
Antibiotic-resistant pneumococcal disease in South African children.
Am J Dis Child. 1992 Aug;146(8):920-3. doi: 10.1001/archpedi.1992.02160200042023.
9
Antimicrobial resistance in Streptococcus pneumoniae: an overview.
Clin Infect Dis. 1992 Jul;15(1):77-83. doi: 10.1093/clinids/15.1.77.
10
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
Clin Infect Dis. 1992 Jul;15(1):119-27. doi: 10.1093/clinids/15.1.119.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验